Association of C49620T ABCC8 polymorphism with anthropometric and metabolic parameters in patients with autosomal dominant polycystic kidney disease: A preliminary study

Nefrologia

Volumn 32, Issue 2, 2012, Pages 153-159

  Pietrzak Nowacka, Maria ^a   Safranow, Krzysztof ^a   Bińczak Kuleta, Agnieszka ^a   Rózański, Jacek ^a   Ciechanowski, Kazimierz ^a   Ciechanowicz, Andrzej ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

ABCC8; ADPKD; Genetic polymorphism; Insulin sensitivity; Obesity; Pancreatic beta cell secretory function

Indexed keywords

ABC TRANSPORTER; DRUG RECEPTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL; SULFONYLUREA RECEPTOR;

ADULT; ARTICLE; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; KIDNEY POLYCYSTIC DISEASE; MALE; METABOLISM; MORPHOMETRICS; PATHOPHYSIOLOGY;

ADULT; ATP-BINDING CASSETTE TRANSPORTERS; BODY WEIGHTS AND MEASURES; FEMALE; HUMANS; MALE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; POLYMORPHISM, GENETIC; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG;

EID: 84864415198     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2011.Nov.11106     Document Type: Article

References (37)

1. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis 1983;2:630-9.
2. The polycystic kidney disease I gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell 1994;77:881-94.
3. Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connoly CJ, Somlo S. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4 q13-q23. Genomics 1993;18:467-72.
4. Binczak-Kuleta A, Rozanski J, Domanski L, Myslak M, Ciechanowski K, Ciechanowicz A. DNA microsatellite analysis in families with autosomal dominant polycystic kidney disease (ADPKD): the first Polish study. J Appl Genet 2006;47:383-9.
5. Joly D, Hummel A, Ruello A, Knebelmann B. Ciliary function of polycystins: a new model for cystogenesis. Nephrol Dial Transplant 2003;18:1689-92.
6. Ducloux D, Motte G, Vautrin P, Bresson-Vautrin C, Rebibou JM, Chalopin JM. Polycystic kidney disease as a risk factor for posttransplant diabetes mellitus. Nephrol Dial Transplant 1999;14:1244-6.
7. de Mattos AM, Olyaei AJ, Prather JC, Golconda MS, Barry JM, Norman DJ. Autosomal-dominant polycystic kidney disease as a risk factor fordiabetes mellitus following renal transplantation. Kidney Int 2005;67:714-20.
8. Hamer RA, Chow ChL, Ong AC, Mc Kane WS. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 2007;83:36-40.
9. Gentil MA, Luna E, Rodríguez-Algarra G, Osuna A, González-Molina M, Mazuecos A, et al. Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant 2002;17:887-91.
10. Pietrzak-Nowacka M, Safranow K, Rózański J, De,bska-Śilzień A, Domański L, Dziewanowski K, et al. Autosomal dominant polycystic kidney disease is not the risk factor for post-transplant diabetes mellitus. Matched-pair design multicenter study. Arch Med Res 2008;39:312-9.
11. Pietrzak-Nowacka M, Rózański J, Safranow K, Kedzierska K, Dutkiewicz G, Ciechanowski K. Autosomal dominant polycystic kidney disease reduces the risk of diabetes mellitus. Arch Med Res 2006;37:360-4.
12. Vareesangthip K, Tong P, Wilkinson R, Thomas TH. Insulin resistance in adult polycystic kidney disease. Kidney Int 1997;52:503-8.
13. Fliser D, Pacini G, Engelletter R, Kautzky-Willer A, Prager R, Franek E, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998;53:1343-7.
14. Thomas PM, Cote GJ, Wohllk N, Kautzky-Willer A, Prager R, Franek E, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycaemia of infancy. Science 1995;268:426-9.
15. Inoue H, Ferrer J, Welling CM, Elbein SC, Hoffman M, Mayorga R, et al. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians. Diabetes 1996;45:825-31.
16. Hart LM, de Knijff P, Dekker JM, Stolk RP, Nipels G, van der Does FE, et al. Variants in the sulphonylurea receptor gene: association of the exon 16-3t variant with Type II diabetes mellitus in Dutch Caucasians. Diabetologia 1999;42:617-20.
17. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, et al. Large-Scale Association Studies of Variants in Genes Encoding the Pancreatic beta -Cell KATP Channel Subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) Confirm that the KCNJ11 E23K Variant Is Associated With Type 2 Diabetes. Diabetes 2003;52:568-72.
18. Van Tilburg JH, Rozeman LB, van Someren H, Ritgers-Aris CA, Freriks JP, Pearson PL, et al. The exon 16-3t variant of the sulphonylurea receptor gene is not a risk factor for Type II diabetes mellitus in the Dutch Breda cohort. Diabetologia 2000;43:681-2.
19. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994;343:824-27.
20. WHO: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation Part 1. Diagnosis and classification of diabetes mellitus. Geneva: WHO; 1999.
21. Stumvoll M, Haeften TV, Fritsche A, Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001;24:796-7.
22. Abbasi F, Reaven GM. Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 2002;51:235-7.
23. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2.
24. Haffner SM, Kennedy E, Gonzales C, Stern MP, Miettinen H. A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care 1996;19:1138-41.
25. Tschritter O, Fritsche A, Shirkavand F, Machicao F, Haring H, Stumvoll M. Assessing the shape of the glucose curve during an oral glucose tolerance test. Diabetes Care 2003;26:1026-33.
26. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999;22:1462-70.
27. Cederholm J, Wibell L. Evaluation of insulin release and relative peripheral resistance with use of the oral gluose tolerance test; a study in subjects with normoglycaemia, glucose intolerance and non-insulindependent diabetes mellitus. Scand J Clin Lab Invest 1985;45:741-51.
28. Pietrzak-Nowacka M, Safranow K, Byra E, Nowosiad M, Marchelek- Myśliwiec M, Ciechanowski K. Glucose metabolism parameters during an oral glucose tolerance test in patients with autosomal dominant polycystic kidney disease. Scand J Clin Lab Invest 2010;70:561-7.
29. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992;15:318-68.
30. Pietrzak-Nowacka M, Safranow K, Bińczak-Kuleta A, Byra E, Ciechanowicz A, Ciechanowski K. Metabolic syndrome components in patients with autosomal-dominant polycystic kidney disease. Kidney Blood Press Res 2009;32:405-10.
31. Stefański A, Majkowska L, Ciechanowicz A, Franków M, Parczewski M, Pilarska K. The common C49620T polymorphism in the sulfonylurea receptor gene (ABCC8), pancreatic beta cell function and long-term diabetic complications in obese patients with long-lasting type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 2007;115:317-21.
32. Hansen T, Echwald SM, Hansen L, Møller AM, Almind K, Clausen JO, et al. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes. 1998;47:598-605.
33. Hart LM, Dekker JM, van Haeften TW, Ruige JB, Stehouwer CD, Erkelens DW, et al. Reduced second phase insulin secretion in carriers of a suphonylurea receptor gene variant associating with type II diabetes mellitus. Diabetologia 2000;43:515-9.
34. Meirhaeghe A, Helbeque N, Cottel D, et al. Impact of sulfonylurea receptor 1 genetic variability on non-insulin dependent diabetes mellitus prevalence and treatment: a population study. Am J Med Genet 2001;105:4-70.
35. Nikolac N, Simundic AM, Katalinic D, Topic E, Cipak A, Rotkvic VZ. Metabolic control in type 2 diabetes is associated with sulfonylureareceptor-1 (SUR-1) but not with KCNJ11 polymorphisms. Arch Med Res 2009;40:387-92.
36. Weisnagel SJ, Rankinen T, Nadeau A, Rao DC, Chagnon YC, Pérusse L, et al. Decreased fasting and oral glucose stimulated C-peptide in nondiabetic subjects with sequence variants in the sulfonylurea receptor 1 gene. Diabetes 2001;50:697-702.
37. Elbein SC, Sun J, Scroggin E, Teng K, Hasstedt SJ. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds. Diabetes Care 2001;24:472-8.